274 related articles for article (PubMed ID: 16277697)
41. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
42. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.
Niewold TB; Harrison MJ; Paget SA
QJM; 2007 Apr; 100(4):193-201. PubMed ID: 17434910
[TBL] [Abstract][Full Text] [Related]
43. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
[TBL] [Abstract][Full Text] [Related]
44. [Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis: a meta-analysis].
Huang QS; Wan LG; Luo ZQ; Le AP; Wang WQ
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2182-7. PubMed ID: 17064503
[TBL] [Abstract][Full Text] [Related]
45. The window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics.
Willemze A; van der Linden MP; le Cessie S; Trouw LA; Toes RE; Huizinga TW; van der Helm-van Mil AH
Ann Rheum Dis; 2011 Sep; 70(9):1697-8. PubMed ID: 21482537
[No Abstract] [Full Text] [Related]
46. CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints.
Rodríguez-Bayona B; Pérez-Venegas JJ; Rodríguez C; Brieva JA
Rheumatology (Oxford); 2007 Apr; 46(4):612-6. PubMed ID: 17132692
[TBL] [Abstract][Full Text] [Related]
47. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
[TBL] [Abstract][Full Text] [Related]
48. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.
Scherer HU; van der Woude D; Ioan-Facsinay A; el Bannoudi H; Trouw LA; Wang J; Häupl T; Burmester GR; Deelder AM; Huizinga TW; Wuhrer M; Toes RE
Arthritis Rheum; 2010 Jun; 62(6):1620-9. PubMed ID: 20178128
[TBL] [Abstract][Full Text] [Related]
49. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.
Amezcua-Guerra LM; Springall R; Marquez-Velasco R; Gómez-García L; Vargas A; Bojalil R
Arthritis Res Ther; 2006; 8(5):R144. PubMed ID: 16934155
[TBL] [Abstract][Full Text] [Related]
50. Anti-CCP antibodies: the past, the present and the future.
van Venrooij WJ; van Beers JJ; Pruijn GJ
Nat Rev Rheumatol; 2011 Jun; 7(7):391-8. PubMed ID: 21647203
[TBL] [Abstract][Full Text] [Related]
51. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis.
Suwannalai P; Trouw LA; Toes RE; Huizinga TW
Mod Rheumatol; 2012 Feb; 22(1):15-20. PubMed ID: 21732051
[TBL] [Abstract][Full Text] [Related]
52. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
Jansen TL
Ned Tijdschr Geneeskd; 2003 Apr; 147(15):729-30; author reply 730-1. PubMed ID: 12722537
[No Abstract] [Full Text] [Related]
53. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.
Pruijn GJ; Wiik A; van Venrooij WJ
Arthritis Res Ther; 2010; 12(1):203. PubMed ID: 20236483
[TBL] [Abstract][Full Text] [Related]
54. Anti-citrullinated peptide antibodies is more than an accurate tool for diagnosis of rheumatoid arthritis.
Goldman K; Gertel S; Amital H
Isr Med Assoc J; 2013 Sep; 15(9):516-9. PubMed ID: 24340846
[TBL] [Abstract][Full Text] [Related]
55. Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis.
Suwannalai P; van de Stadt LA; Radner H; Steiner G; El-Gabalawy HS; Zijde CM; van Tol MJ; van Schaardenburg D; Huizinga TW; Toes RE; Trouw LA
Arthritis Rheum; 2012 May; 64(5):1323-8. PubMed ID: 22130974
[TBL] [Abstract][Full Text] [Related]
56. Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons.
Alivernini S; Galeazzi M; Peleg H; Tolusso B; Gremese E; Ferraccioli G; Naparstek Y
Autoimmun Rev; 2017 Nov; 16(11):1096-1102. PubMed ID: 28899798
[TBL] [Abstract][Full Text] [Related]
57. Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?
Gao IK; Haas-Wöhrle A; Mueller KG; Lorenz HM; Fiehn C
Ann Rheum Dis; 2005 Oct; 64(10):1516-7. PubMed ID: 16162906
[No Abstract] [Full Text] [Related]
58. The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis.
van der Woude D; Syversen SW; van der Voort EI; Verpoort KN; Goll GL; van der Linden MP; van der Helm-van Mil AH; van der Heijde DM; Huizinga TW; Kvien TK; Toes RE
Ann Rheum Dis; 2010 Jun; 69(6):1110-6. PubMed ID: 20439289
[TBL] [Abstract][Full Text] [Related]
59. [Association between bone catabolism and anti-citrullinated protein antibodies in rheumatoid arthritis].
Harre U; Schett G
Z Rheumatol; 2016 Oct; 75(8):809-811. PubMed ID: 27444625
[TBL] [Abstract][Full Text] [Related]
60. ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression.
van Beers JJ; Willemze A; Jansen JJ; Engbers GH; Salden M; Raats J; Drijfhout JW; van der Helm-van Mil AH; Toes RE; Pruijn GJ
Arthritis Res Ther; 2013 Oct; 15(5):R140. PubMed ID: 24286543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
